1 |
Vasquez D , Castrillón MS , Vega MG , Henck CG , Aguillon D , Garcia-Cifuentes E , Jaramillo-Jimenez A , Velez JE , Madrigal L , Lopera F . Quality of life in early-onset Alzheimer's disease due to a PSEN1-E280A mutation. Neurol Sci, 2021, 42: 4637- 4645.
doi: 10.1007/s10072-021-05136-y
|
2 |
Mao C , Li J , Dong L , Huang X , Lei D , Wang J , Chu S , Liu C , Peng B , Román GC , Cui L , Gao J . Clinical phenotype and mutation spectrum of Alzheimer's disease with causative genetic mutation in a Chinese cohort. Curr Alzheimer Res, 2021, 18: 265- 272.
doi: 10.2174/1567205018666210608120339
|
3 |
Wu L , Rosa-Neto P , Hsiung GY , Sadovnick AD , Masellis M , Black SE , Jia J , Gauthier S . Early-onset familial Alzheimer's disease (EOFAD). Can J Neurol Sci, 2012, 39: 436- 445.
doi: 10.1017/S0317167100013949
|
4 |
Tortelli R , Seripa D , Zecca C , Dell'Abate MT , Bisceglia P , Barulli MR , De Blasi R , Logroscino G . A new Presenilin 1(Psen1) mutation (p. Cys263Trp) as a cause of both early and late-onset Alzheimer's disease in a large Italian family. Int J Mol Sci, 2021, 22: 6215.
doi: 10.3390/ijms22126215
|
5 |
Zhou J , Chen Y , Meng F , Zhang K , Liu X , Peng G . Presenilin 1 and APP gene mutations in early-onset AD families from a southeast region of China. Curr Alzheimer Res, 2020, 17: 540- 546.
doi: 10.2174/1567205017666200624195809
|
6 |
Qin Q , Yin Y , Wang Y , Lu Y , Tang Y , Jia J . Gene mutations associated with early onset familial Alzheimer's disease in China: an overview and current status. Mol Genet Genomic Med, 2020, 8: e1443.
doi: 10.1002/mgg3.1443
|
7 |
Zhang G , Xie Y , Wang W , Feng X , Jia J . Clinical characterization of an APP mutation (V717I) in five Han Chinese families with early-onset Alzheimer's disease. J Neurol Sci, 2017, 372: 379- 386.
doi: 10.1016/j.jns.2016.10.039
|
8 |
Campion D , Dumanchin C , Hannequin D , Dubois B , Belliard S , Puel M , Thomas-Anterion C , Michon A , Martin C , Charbonnier F , Raux G , Camuzat A , Penet C , Mesnage V , Martinez M , Clerget-Darpoux F , Brice A , Frebourg T . Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet, 1999, 65: 664- 670.
doi: 10.1086/302553
|
9 |
Schüle R , Wiethoff S , Martus P , Karle KN , Otto S , Klebe S , Klimpe S , Gallenmüller C , Kurzwelly D , Henkel D , Rimmele F , Stolze H , Kohl Z , Kassubek J , Klockgether T , Vielhaber S , Kamm C , Klopstock T , Bauer P , Züchner S , Liepelt-Scarfone I , Schöls L . Hereditary spastic paraplegia: clinicogenetic lessons from 608 patients. Ann Neurol, 2016, 79: 646- 658.
doi: 10.1002/ana.24611
|
10 |
Loureiro JL , Brandão E , Ruano L , Brandão AF , Lopes AM , Thieleke-Matos C , Miller-Fleming L , Cruz VT , Barbosa M , Silveira I , Stevanin G , Pinto-Basto J , Sequeiros J , Alonso I , Coutinho P . Autosomal dominant spastic paraplegias: a review of 89 families resulting from a portuguese survey. JAMA Neurol, 2013, 70: 481- 487.
doi: 10.1001/jamaneurol.2013.1956
|
11 |
McDermott CJ , Burness CE , Kirby J , Cox LE , Rao DG , Hewamadduma C , Sharrack B , Hadjivassiliou M , Chinnery PF , Dalton A , Shaw PJ , UK and Irish HSP Consortium . Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology, 2006, 67: 45- 51.
doi: 10.1212/01.wnl.0000223315.62404.00
|
12 |
Uttner I , Kirchheiner J , Tumani H , Mottaghy FM , Lebedeva E , Ozer E , Ludolph AC , Huber R , von Arnim CA . A novel presenilin1 mutation (Q223R) associated with early onset Alzheimer's disease, dysarthria and spastic paraparesis and decreased Abeta levels in CSF. Eur J Neurol, 2010, 17: 631- 633.
doi: 10.1111/j.1468-1331.2009.02810.x
|
13 |
Oakley DH , Klickstein N , Commins C , Chung M , Dujardin S , Bennett RE , Hyman BT , Frosch MP . Continuous monitoring of tau-induced neurotoxicity in patient-derived iPSC -neurons. J Neurosci, 2021, 41: 4335- 4348.
doi: 10.1523/JNEUROSCI.2590-20.2021
|
14 |
Cistaro A , Quartuccio N , Cassalia L , Vai D , Guerra UP , Atzori C , Rainero I , Imperiale D . Brain 18F-Florbetapir PET/CT findings in an early-onset Alzheimer disease patient carrying presenilin-1 G378E mutation. Alzheimer Dis Assoc Disord, 2022, 36: 347- 349.
doi: 10.1097/WAD.0000000000000461
|
15 |
Gordon BA , Blazey TM , Su Y , Hari-Raj A , Dincer A , Flores S , Christensen J , McDade E , Wang G , Xiong C , Cairns NJ , Hassenstab J , Marcus DS , Fagan AM , Jack CR Jr , Hornbeck RC , Paumier KL , Ances BM , Berman SB , Brickman AM , Cash DM , Chhatwal JP , Correia S , Förster S , Fox NC , Graff-Radford NR , la Fougère C , Levin J , Masters CL , Rossor MN , Salloway S , Saykin AJ , Schofield PR , Thompson PM , Weiner MM , Holtzman DM , Raichle ME , Morris JC , Bateman RJ , Benzinger TLS . Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. Lancet Neurol, 2018, 17: 241- 250.
doi: 10.1016/S1474-4422(18)30028-0
|
16 |
Yau WW , Tudorascu DL , McDade EM , Ikonomovic S , James JA , Minhas D , Mowrey W , Sheu LK , Snitz BE , Weissfeld L , Gianaros PJ , Aizenstein HJ , Price JC , Mathis CA , Lopez OL , Klunk WE . Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study. Lancet Neurol, 2015, 14: 804- 813.
doi: 10.1016/S1474-4422(15)00135-0
|
17 |
Kondo T , Banno H , Okunomiya T , Amino Y , Endo K , Nakakura A , Uozumi R , Kinoshita A , Tada H , Morita S , Ishikawa H , Shindo A , Yasuda K , Taruno Y , Maki T , Suehiro T , Mori K , Ikeda M , Fujita K , Izumi Y , Kanemaru K , Ishii K , Shigenobu K , Kutoku Y , Sunada Y , Kawakatsu S , Shiota S , Watanabe T , Uchikawa O , Takahashi R , Tomimoto H , Inoue H . Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1(PSEN1) mutations. BMJ Open, 2021, 11: e051343.
doi: 10.1136/bmjopen-2021-051343
|
18 |
Revi M . Alzheimer's disease therapeutic approaches. Adv Exp Med Biol, 2020, 1195: 105- 116.
|
19 |
Breijyeh Z , Karaman R . Comprehensive review on Alzheimer's disease: causes and treatment. Molecules, 2020, 25: 5789.
doi: 10.3390/molecules25245789
|
20 |
Kovács T . Therapy of Alzheimer disease. Neuropsychopharmacol Hung, 2009, 11: 27- 33.
|
21 |
Zhang Y , Sun MF , Jia ZY , Jiang JW , Wang YL , Xu J . Early-onset Alzheimer's disease caused by PSEN1 gene mutation: two cases reports and literature review. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2021, 21: 967- 975.
URL
|
|
张源, 孙梦凡, 贾紫嫣, 姜季委, 王艳丽, 徐俊. PSEN1基因变异致早发性阿尔茨海默病两例报道并文献复习. 中国现代神经疾病杂志, 2021, 21: 967- 975.
URL
|